Full treatment of the costs and benefits is needed

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7065.1143 (Published 02 November 1996) Cite this as: BMJ 1996;313:1143
  1. A S Wierzbicki,
  2. T M Reynolds
  1. Senior lecturer in chemical pathology St Thomas's Hospital, London SE1 7EH
  2. Consultant chemical pathologist Burton Hospitals, Burton on Trent, Staffordshire DE13 0RB

    EDITOR,—P D P Pharoah and W Hollingworth have produced an interesting article that is of little benefit to the debate on the health economics of lowering lipid concentrations.1 The life table approach suffers from the same deficiency as we2 have pointed out for the Sheffield risk factor table.3 Megnien et al have shown that the risk table does not differ significantly from the currently accepted guidelines …

    View Full Text

    Sign in

    Log in through your institution